Ensol Biosciences Inc. announced a private placement of round 2 non-guaranteed private convertible bonds with bearer interest for gross proceeds of KRW 2,000,000,000 on December 24, 2021. The transaction will include participation from Korea Bio Unicorn Private Equity Joint Venture Specializing in Startup Ventures. The bonds does not bear any interest and matures on January 04, 2027. The bonds are fully convertible into 141,342 shares representing 1.40% stake at a fixed conversion price of KRW 14,150 per share between January 04, 2023 and December 04, 2026. The subscription date is January 03, 2022 and payment date is January 04, 2022. The bonds are subject to 1 year restriction. The transaction is approved by the board of directors of the company.